Table 2. Comparison of DS+AVSD significantly associated CNVs from Sailani and co-workers to our current study.
Sailani and Co-workers’ CGH Results | Our CGH Results | ||||||||
---|---|---|---|---|---|---|---|---|---|
Cases (n = 53) | Controls (n = 55) | Cases (n = 198) | Controls (n = 222) | ||||||
DS+AVSD | DS+NH | DS+AVSD | DS+NH | ||||||
Coordinates (hg19) | Deletion Frequency | Duplication Frequency | Deletion Frequency | Duplication Frequency | Deletion Frequency | Duplication Frequency | Deletion Frequency | Duplication Frequency | |
CNV1 | chr21:43,193,374–43,198,244 | 0.18 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 |
CNV2 | chr21:43,411,411–43,413,231 | 0.24 | 0.14 | 0 | 0.11 | N/A | N/A | N/A | N/A |
We did not replicate the previously reported significant association of common deletions and duplications at CNV1 in the study by Sailani et al. (2013). Our CGH array did not have at least six probes inside CNV2 and thus was undetectable by our methodology. CGH, comparative genomic hybridization; DS+AVSD, individuals with Down syndrome and complete atrioventricular septal defect; DS+NH, individuals with Down syndrome without a congenital heart defect (i.e., normal heart); CNV, copy number variant; chr21, chromosome 21.